Arthur F Ryan - Director, Regeneron Pharmaceuticals, Inc

As of May 3, 2022


Arthur F Ryan Net Worth

  • Net worth is estimated to be at least $74.25M
  • Owns at least 22,182 units of Regeneron Pharmaceuticals, Inc stock
  • Sold an estimated value of $53.74M in the last 18 years at Regeneron Pharmaceuticals, Inc

Arthur F Ryan Trading

  • Largest purchase of shares was 50,124 units , worth over $18.73M on May 7, 2020
  • Largest sale of shares was 50,124 units , worth over $27.61M on May 7, 2020
  • In total has made about 51 transactions over 18 years
  • Usually trades in January, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Arthur F Ryan Mailing Address

  • Mailing address is Citizens Financial Group, Inc 600 Washington Boulevard Stamford CT 06901 CT

Regeneron Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Leonard S. Schleifer, M.D., Ph.D. 2020 $1,480,119 $130,000,032 $3,567,714 $3,567,714 $302,256 $135,350,121
Leonard S. Schleifer, M.D., Ph.D. 2019 $1,377,100 $4,983,226 $3,057,162 $3,057,162 $338,043 $21,455,117
Leonard S. Schleifer, M.D., Ph.D. 2018 $1,330,500 - $2,953,710 $2,953,710 $896,432 $26,520,555
George D. Yancopoulos, M.D., Ph.D. 2020 $1,258,096 $130,000,032 $3,004,391 $3,004,391 $120,800 $134,383,319
George D. Yancopoulos, M.D., Ph.D. 2019 $1,170,500 $4,983,226 $2,598,510 $2,598,510 $212,313 $20,664,135
George D. Yancopoulos, M.D., Ph.D. 2018 $1,130,900 - $2,510,598 $2,510,598 $399,718 $25,381,129
Robert E. Landry 2020 $825,577 $949,560 $938,872 $938,872 $24,195 $6,197,703
Robert E. Landry 2019 $730,000 $2,840,008 $811,395 $811,395 $23,470 $7,931,542
Robert E. Landry 2018 $680,000 $4,767,500 $581,400 $581,400 $19,535 $9,356,619
Daniel P. Van Plew 2020 $825,577 $3,409,560 $938,872 $938,872 $20,945 $8,654,453
Daniel P. Van Plew 2019 $683,100 $2,840,008 $759,266 $759,266 $20,470 $7,829,513
Daniel P. Van Plew 2018 $660,000 - $677,160 $677,160 $19,915 $9,007,222
Andrew J. Murphy, Ph.D. 2020 $726,923 $5,025,288 $887,250 $887,250 $24,195 $10,998,914
Andrew J. Murphy, Ph.D. 2019 $600,000 $4,702,308 $666,900 $666,900 $23,470 $9,519,347
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/872589/000093041321000869/c101011_def14a.htm

Regeneron Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 10,000 units sold on May 18, 2022 by Andrew Murphy worth over $6.54M
  • In the last 19 years, insiders at Regeneron Pharmaceuticals, Inc sold an estimated value of $17.26B and bought an estimated value of $3.4B
  • The most active traders are Joseph L Goldstein, Director,  Michael S Brown, Director,  and P. Roy Vagelos, Director
  • Insider trading is most common in December, with the busiest year in 2014

REGENERON PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1